Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Benzocaine 100 mg/g dental gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
Product containing precisely benzocaine 200 milligram/1 gram conventional release dental gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
Benzocaine poisoning |
Causative agent |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Accidental benzocaine poisoning |
Causative agent |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
Intentional benzocaine poisoning |
Causative agent |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
forgiftning med benzocain, uvist med hvilken hensigt |
Causative agent |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Benzocaine adverse reaction |
Causative agent |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Allergy to benzocaine (finding) |
Causative agent |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
Benzocaine overdose (disorder) |
Causative agent |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Accidental benzocaine overdose |
Causative agent |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Intentional benzocaine overdose |
Causative agent |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
overdosis af benzocain, uvist med hvilken hensigt |
Causative agent |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
kombinationspræparat med benzocain 100 mg sugetablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
benzocain 1 mg halsspray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
Benzocaine 30 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
Benzocaine 10 mg/mL and triclosan 2 mg/mL cutaneous spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
Product containing precisely benzocaine 10 milligram/1 milliliter and triclosan 2 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
Benzocaine 10 mg/g and triclosan 2 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
Benzocaine compound injection solution BPC vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
Benzocaine 20% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
Benzocaine 200 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
benzocain 20 % salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
benzocain 20 % øredråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
benzocain 2% wt/wt + trimethobenzamidhydrochlorid 100 mg suppositorier |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
Product containing benzocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Antipyrine + benzocaine + glycerin 54mg/14mg/1cc solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
antipyrin + benzocain 5,4 % vægtvolumen/1,442 % vægtvolumen-opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
benzocain + trimethobenzamidhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
pyrilaminmaleat + benzocain |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
Benzocaine 10 mg and dequalinium chloride 250 microgram oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
kombinationspræparat med benzocain 100 mg + menthol 3 mg sugetablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
benzocain + butamben + tetracainhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
benzocain + butamben + tetracainhydrochlorid 14 % wt/wt/2 % wt/wt/2 % wt/wt aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
benzocain 14 % wt/wt + butamben 2 % wt/wt + tetracainhydrochlorid 2 % wt/wt gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
benzocain + butamben + tetracainhydrochlorid 14 % wt/wt/2 % wt/wt/2 % wt/wt væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
benzocain 14 % wt/wt + butamben 2 % wt/wt + tetracainhydrochlorid 2 % wt/wt salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
Product containing benzocaine and phenazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing benzocaine and menthol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing benzocaine and resorcinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing benzocaine and phenazone and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing benzocaine and phenol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing benzocaine and triclosan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
Accidental benzocaine poisoning |
Causative agent |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Intentional benzocaine poisoning |
Causative agent |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing benzocaine and mepyramine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing benzocaine and cetylpyridinium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing benzocaine and dequalinium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing benzocaine and chloroxylenol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing benzocaine and salicylamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing benzocaine and tyrothricin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
Benzocaine-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing benzocaine in oropharyngeal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing benzocaine in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
Product containing benzocaine in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing benzocaine in vaginal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Allergy to benzocaine (finding) |
Causative agent |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Benzocaine + trimethobenzamide hydrochloride 2%ww/100mg rectal suppositories |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
Benzocaine 10 mg and dequalinium chloride 250 microgram oromucosal lozenge |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Benzocaine 10 mg and dequalinium chloride 250 microgram oromucosal lozenge |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing benzocaine in dental dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Benzocaine 30 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Benzocaine 30 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Benzocaine 100 mg/g dental gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Benzocaine 100 mg/g dental gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely benzocaine 200 milligram/1 gram conventional release dental gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely benzocaine 200 milligram/1 gram conventional release dental gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
Benzocaine 10 mg/g and triclosan 2 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
Benzocaine 10 mg/g and triclosan 2 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Benzocaine-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Benzocaine- and cetylpyridinium-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing benzocaine and dequalinium in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Benzocaine- and mepyramine-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing benzocaine and salicylamide in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
Benzocaine- and tyrothricin-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing benzocaine and chloroxylenol in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Benzocaine- and triclosan-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing only benzocaine and chloroxylenol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Benzocaine and mepyramine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing only benzocaine and dequalinium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing only benzocaine and menthol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Benzocaine and phenol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing only benzocaine and cetylpyridinium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing only benzocaine and phenazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing only benzocaine and resorcinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing only benzocaine and salicylamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |